RESUMEN
Intravitreal tnaincinolone acetonide has been used in numerous pathologies diabetic macular edema is one of them Our study is prospective including 20 eyes of diabetic patients with diabetic macular edema They underwent intravitreal injection of 4 mg of triamcinolone when visual acuity is under 3/10 Our aim is to describe the main complications noted High intraocular pressure was noted in 20% of cases but this elevation was transitory and controlled with topical medications in all patients. Lens opacification occurs also in 20% of our patients and interested among all posterior subcapsular but also cortical layers. We noted that half of the patients that presented high intraocular pressure developed cataract. None of our patients developed the other intraocular injection complications: no case of endophtalmitis or pseudohypopion, no retinal detachment or intravitreal hemorrhage, no case of cortisone crystals settling on the macular region. We think that these complications may not dissuade of practicing intravitreal injection of Triamcinolone